Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13132)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2017 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Giordano G, Pancione M, Olivieri N, Parcesepe P, Velocci M, Di Raimo T, Coppola L, Toffoli G, D’Andrea MR. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World J Gastroenterol 2017; 23(32): 5875-5886 [PMID: 28932079 DOI: 10.3748/wjg.v23.i32.5875] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v23/i32/5875.htm |
| Number | Citing Articles |
| 1 |
Barbara Burgos-Blasco, Samuel Hernandez-Ruiz, Lorenzo Lopez-Guajardo, Juan Donate-Lopez. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy. American Journal of Ophthalmology Case Reports 2020; 18: 100653 doi: 10.1016/j.ajoc.2020.100653
|
| 2 |
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome. Scandinavian Journal of Gastroenterology 2020; 55(6): 725 doi: 10.1080/00365521.2020.1774923
|
| 3 |
Xiangli Bai, Jia Xiong, Lin Li, Chao Yu, Chengyi Sun. Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer. European Journal of Pharmacology 2024; 969: 176431 doi: 10.1016/j.ejphar.2024.176431
|
| 4 |
Mugahed Abdullah Hasan Albahde, Bulat Abdrakhimov, Guo-Qi Li, Xiaohu Zhou, Dongkai Zhou, Hao Xu, Huixiao Qian, Weilin Wang. The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.640863
|
| 5 |
Rujing Chen, Leaf Huang, Kaili Hu. Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharmaceutica Sinica B 2020; 10(11): 2140 doi: 10.1016/j.apsb.2020.04.005
|
| 6 |
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920915978
|
| 7 |
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment. 2021; : 91 doi: 10.1007/978-3-030-68334-4_7
|
| 8 |
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, Moon Seungjoon, Moon Nyeo Park, Bonglee Kim. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies. Biomedicine & Pharmacotherapy 2023; 161: 114491 doi: 10.1016/j.biopha.2023.114491
|
| 9 |
Pengcheng Zhang, He Tao, Liyang Yu, Lixiao Zhou, Chenggang Zhu. Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems. Drug Delivery 2020; 27(1): 491 doi: 10.1080/10717544.2020.1745327
|
| 10 |
Weiwei Li, Gregory C. Wilson, Magdalena Bachmann, Jiang Wang, Andrea Mattarei, Cristina Paradisi, Michael J. Edwards, Ildiko Szabo, Erich Gulbins, Syed A. Ahmad, Sameer H. Patel. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers 2022; 14(11): 2618 doi: 10.3390/cancers14112618
|
| 11 |
Jonas Dinter, Ralf P. Friedrich, Hai Yang, Christian Pilarsky, Harald Mangge, Marina Pöttler, Christina Janko, Christoph Alexiou, Stefan Lyer. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Materials 2023; 16(7): 2906 doi: 10.3390/ma16072906
|
| 12 |
Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel. Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial. Journal of Geriatric Oncology 2022; 13(5): 662 doi: 10.1016/j.jgo.2021.12.018
|
| 13 |
Eudald Casals, Michele Vitali, Victor Puntes. The nanoparticle-Protein Corona untold history (1907–2007). Nano Today 2024; 58: 102435 doi: 10.1016/j.nantod.2024.102435
|
| 14 |
Naureen Ali, Nimisha Srivastava. Recent Advancements for the Management of Pancreatic Cancer: Current Insights. Current Cancer Therapy Reviews 2021; 17(4): 267 doi: 10.2174/1573394717666210625153256
|
| 15 |
Carsten Höltke, Martin Grewer, Miriam Stölting, Christiane Geyer, Moritz Wildgruber, Anne Helfen. Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution. Molecular Pharmaceutics 2021; 18(7): 2574 doi: 10.1021/acs.molpharmaceut.1c00064
|
| 16 |
Daniel M. Makanyane, Sanam Maikoo, Fanie R. Van Heerden, Lydia Rhyman, Ponnadurai Ramasami, Lindokuhle P. Mabuza, Phikelelani Ngubane, Andile Khathi, Allen Mambanda, Irvin N. Booysen. Bovine serum albumin uptake and polypeptide disaggregation studies of hypoglycemic ruthenium(II) uracil Schiff-base complexes. Journal of Inorganic Biochemistry 2024; 255: 112541 doi: 10.1016/j.jinorgbio.2024.112541
|
| 17 |
Wanchun Zheng, Shouming Xu. <p>Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics</p>. OncoTargets and Therapy 2020; : 10297 doi: 10.2147/OTT.S259895
|
| 18 |
Matthew C Phillips, Shaker A Mousa. Clinical Application of Nano-Targeting for Enhancing Chemotherapeutic Efficacy and Safety in Cancer Management. Nanomedicine 2022; 17(6): 405 doi: 10.2217/nnm-2021-0361
|
| 19 |
Mahfoozur Rahman, Kainat Alam, Shipra Daniel, Afroze Alam, Sarwar Beg. Hormone Related Cancer Mechanistic and Nanomedicines. 2022; : 1 doi: 10.1007/978-981-19-5558-7_1
|
| 20 |
Rui Cao, Wenping Song, Cheng Ye, Xiujun Liu, Liang Li, Yi Li, Hongjuan Yao, Xiaofei Zhou, Liang Li, Rongguang Shao. Internal enhancement of DNA damage by a novel bispecific antibody‐drug conjugate‐like therapeutics via blockage of mTOR and PD‐L1 signal pathways in pancreatic cancer. Cancer Medicine 2019; 8(2): 643 doi: 10.1002/cam4.1974
|
| 21 |
Julia Salapa, Allison Bushman, Kevin Lowe, Joseph Irudayaraj. Nano drug delivery systems in upper gastrointestinal cancer therapy. Nano Convergence 2020; 7(1) doi: 10.1186/s40580-020-00247-2
|
| 22 |
Hafiza Padinharayil, Vikrant Rai, Alex George. Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy. Cancers 2023; 15(4): 1070 doi: 10.3390/cancers15041070
|
| 23 |
Sarah L. Skoczen, Kelsie S. Snapp, Rachael M. Crist, Darby Kozak, Xiaohui Jiang, Hao Liu, Stephan T. Stern. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay. ACS Pharmacology & Translational Science 2020; 3(3): 547 doi: 10.1021/acsptsci.0c00011
|
| 24 |
Xiangyu Fan, Haiyun Wu, Lisong Zhao, Xu Guo. A Poly-Chitosan and Cis-Platinum Conjugated Composite Nanoparticle System for Liver Cancer Therapy. Journal of Biomedical Nanotechnology 2021; 17(9): 1726 doi: 10.1166/jbn.2021.3157
|
| 25 |
Sreejith Thrivikraman Nair, C Abhi, Kaladhar Kamalasanan, K. Pavithran, Ashok R. Unni, MS Sithara, Manjit Sarma, T S Mangalanandan. Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer. Molecular Pharmaceutics 2024; doi: 10.1021/acs.molpharmaceut.4c00801
|
| 26 |
Tao Ma, Jin-Ling Jiang, Wei-Xiang Qi, Jia-Yi Chen, Hao-Ping Xu. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. Drug Design, Development and Therapy 2022; : 2395 doi: 10.2147/DDDT.S366558
|
| 27 |
Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, Yuki Homma, Robert M. Hoffman, Itaru Endo. Role of the tumor microenvironment in pancreatic cancer. Annals of Gastroenterological Surgery 2019; 3(2): 130 doi: 10.1002/ags3.12225
|
| 28 |
Ishfaq Ahmed, Sam G. Pappas, Ashiq Masood. Animal Models in Cancer Drug Discovery. 2019; : 267 doi: 10.1016/B978-0-12-814704-7.00011-8
|
| 29 |
Sabrina Belbekhouche, Mélissande Cossutta, Damien Habert, Séna Hamadi, Tina Modjinou, Ilaria Cascone, José Courty. N6L-functionalized nanoparticles for targeted and inhibited pancreatic cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 607: 125461 doi: 10.1016/j.colsurfa.2020.125461
|
| 30 |
Cheng Qin, Gang Yang, Jinshou Yang, Bo Ren, Huanyu Wang, Guangyu Chen, Fangyu Zhao, Lei You, Weibin Wang, Yupei Zhao. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01169-7
|
| 31 |
Haonan Li, Runwei Jiao, Jiahui Mu, Shengtao Xu, Xu Li, Xianhua Wang, Zhanlin Li, Jinyi Xu, Huiming Hua, Dahong Li. Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic Derivatives. Molecules 2018; 23(11): 2914 doi: 10.3390/molecules23112914
|
| 32 |
Yan Shi, Quanli Han, Huan Yan, Yao Lv, Jing Yuan, Jie Li, Shasha Guan, Zhikuan Wang, Lei Huang, Guanghai Dai. S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.865404
|
| 33 |
Samantha J. Wade, Zeliha Sahin, Ann‐Katrin Piper, Sepehr Talebian, Morteza Aghmesheh, Javad Foroughi, Gordon G. Wallace, Simon E. Moulton, Kara L. Vine. Dual Delivery of Gemcitabine and Paclitaxel by Wet‐Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation. Advanced Healthcare Materials 2020; 9(21) doi: 10.1002/adhm.202001115
|
| 34 |
Christian Chapa-González, Karina López, Kimberly Michelle Lomelí, Jorge Alberto Roacho-Pérez, Jazmín Cristina Stevens. A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer. Life 2022; 12(3): 327 doi: 10.3390/life12030327
|
| 35 |
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
|
| 36 |
Vidhi M. Shah, Craig Dorrell, Adel Al-Fatease, Brittany L. Allen-Petersen, Yeonhee Woo, Yuliya Bortnyak, Rohi Gheewala, Brett C. Sheppard, Rosalie C. Sears, Adam WG. Alani. Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer. Pharmaceutics 2022; 14(4): 713 doi: 10.3390/pharmaceutics14040713
|
| 37 |
Diane Bressand, Anthony Novell, Alban Girault, William Raoul, Gaëlle Fromont-Hankard, Jean-Michel Escoffre, Thierry Lecomte, Ayache Bouakaz. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model. Molecular Pharmaceutics 2019; 16(9): 3814 doi: 10.1021/acs.molpharmaceut.9b00416
|
| 38 |
Cristina Martín-Sabroso, Ana Isabel Fraguas-Sánchez, Rafaela Raposo-González, Ana Isabel Torres-Suárez. Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research. Current Medicinal Chemistry 2021; 28(17): 3271 doi: 10.2174/0929867327666200819115403
|
| 39 |
Jianwen Zhou, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang, Cuiyan Han. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Delivery 2019; 26(1): 281 doi: 10.1080/10717544.2019.1580799
|
| 40 |
Jungwhoi Lee, Jungsul Lee, Woogwang Sim, Jae-Hoon Kim. Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression. Cancers 2020; 12(2): 277 doi: 10.3390/cancers12020277
|
| 41 |
Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano. Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7530619
|
| 42 |
Mathilde Lorscheider, Alice Gaudin, Jessica Nakhlé, Kadi-Liis Veiman, Joël Richard, Christophe Chassaing. Challenges and Opportunities in the Delivery of Cancer Therapeutics: Update on Recent Progress. Therapeutic Delivery 2021; 12(1): 55 doi: 10.4155/tde-2020-0079
|
| 43 |
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma. Nanoscale 2022; 14(9): 3306 doi: 10.1039/D1NR08394E
|
| 44 |
Haolin Song, Chen Jiang. Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma. Expert Opinion on Drug Delivery 2022; 19(3): 281 doi: 10.1080/17425247.2022.2045943
|
| 45 |
Kazuaki Taguchi, Yuko Okamoto, Kazuaki Matsumoto, Masaki Otagiri, Victor Chuang. When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications. Pharmaceuticals 2021; 14(4): 296 doi: 10.3390/ph14040296
|
| 46 |
Abagail M. Delahoussaye, Joseph Abi Jaoude, Morgan Green, Tara N. Fujimoto, Jessica Molkentine, Carolina J. Garcia Garcia, Jason P. Gay, Ningping Feng, Joseph Marszalek, Natalie Fowlkes, Cullen M. Taniguchi. Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09255-3
|
| 47 |
Priya Mondal, George Alyateem, Allison V. Mitchell, Michael M. Gottesman. A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell line. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66244-1
|
| 48 |
Wanting Hou, Biao Yang, Hong Zhu. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy. Pharmaceutics 2022; 14(10): 2033 doi: 10.3390/pharmaceutics14102033
|
| 49 |
Seung Soo Hong, Sena Lee, Sung Hwan Lee, Seonhowa Kim, Doyoung Kim, Hanseul Park, Jongook Lee, Jung Hwan Lee, Chang Moo Kang. Anticancer effect of locally applicable aptamer‐conjugated gemcitabine‐loaded atelocollagen patch in pancreatic cancer patient–derived xenograft models. Cancer Science 2022; 113(5): 1752 doi: 10.1111/cas.15318
|
| 50 |
Epiphane K. Silli, Mengfei Li, Yuting Shao, Yiran Zhang, Guilin Hou, Jiaqian Du, Jingdan Liang, Ying Wang. Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. European Journal of Pharmaceutics and Biopharmaceutics 2023; 192: 13 doi: 10.1016/j.ejpb.2023.09.014
|
| 51 |
Shiao Li Oei, Friedemann Schad. Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?. Cancers 2023; 15(4): 1116 doi: 10.3390/cancers15041116
|
| 52 |
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Cells 2020; 9(5): 1251 doi: 10.3390/cells9051251
|
| 53 |
Xin Luan, Hebao Yuan, Yudong Song, Hongxiang Hu, Bo Wen, Miao He, Huixia Zhang, Yan Li, Feng Li, Pan Shu, Joseph P. Burnett, Nathan Truchan, Maria Palmisano, Manjunath P. Pai, Simon Zhou, Wei Gao, Duxin Sun. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation. Biomaterials 2021; 275: 120910 doi: 10.1016/j.biomaterials.2021.120910
|
| 54 |
Wangshu Dai, Xin Qiu, Changchang Lu, Zhengyun Zou, Huizi Sha, Weiwei Kong, Baorui Liu, Juan Du. AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693386
|
| 55 |
Jay Natu, Ganji Purnachandra Nagaraju. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies. Cancer Letters 2023; 573: 216382 doi: 10.1016/j.canlet.2023.216382
|
| 56 |
Si Shi, Chen Liang, Jin Xu, Qingcai Meng, Jie Hua, Xiujiang Yang, Quanxing Ni, Xianjun Yu. The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic Cancer. Annals of Surgery 2020; 271(3): 559 doi: 10.1097/SLA.0000000000002998
|
| 57 |
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert, Nicolai Haertel. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4665-2
|
| 58 |
Masahiro Yasunaga, Shino Manabe, Masaru Furuta, Koretsugu Ogata, Yoshikatsu Koga, Hiroki Takashima, Toshirou Nishida, Yasuhiro Matsumura. Mass spectrometry imaging for early discovery and development of cancer drugs. AIMS Medical Science 2018; 5(2): 162 doi: 10.3934/medsci.2018.2.162
|
| 59 |
Yining Tao, Chenxu Yan, Dan Li, Jianfeng Dai, Yingsheng Cheng, Hui Li, Wei-Hong Zhu, Zhiqian Guo. Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic Cancer. JACS Au 2022; 2(1): 246 doi: 10.1021/jacsau.1c00553
|
| 60 |
Ulrich M. Lauer, Can Yurttas, Julia Beil. Cancer Regional Therapy. 2020; : 17 doi: 10.1007/978-3-030-28891-4_2
|
| 61 |
Flore Pignon, Anthony Turpin, Olivia Hentic, Romain Coriat, Emma Salmon, Isabelle Baumgaertner, Nicolas Bertrand, Philippe Lévy, Vinciane Rebours, Pascal Hammel, Louis de Mestier. Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma. Pancreatology 2021; 21(6): 1064 doi: 10.1016/j.pan.2021.05.006
|
| 62 |
Shu Ming Chai, Ser Yee Lee. High Endothelial Venules and Pancreatic Ductal Adenocarcinoma: A potential game changer. EBioMedicine 2019; 39: 29 doi: 10.1016/j.ebiom.2018.11.061
|
| 63 |
Duxin Sun, Simon Zhou, Wei Gao. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right. ACS Nano 2020; 14(10): 12281 doi: 10.1021/acsnano.9b09713
|
| 64 |
Dan Wang, Wenkai Feng, Xiaowei Wang, Dongfang Lin, Xuelei Wang, Xiaoru Guo, Qingfang Miao, Jie Ma, Guimin Xia. Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. European Journal of Pharmaceutical Sciences 2021; 167: 106000 doi: 10.1016/j.ejps.2021.106000
|
| 65 |
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers, Ravi P. Sahu. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers 2019; 11(11): 1627 doi: 10.3390/cancers11111627
|
| 66 |
Penelope Edwards, Byung Woog Kang, Ian Chau. Targeting the Stroma in the Management of Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.691185
|
| 67 |
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
|
| 68 |
Fei‐Ting Hsu, Chang Liang Tsai, I‐Tsang Chiang, Keng‐Hsueh Lan, Po‐Fu Yueh, Wen‐Yi Liang, Chi‐Shuo Lin, Yee Chao, Keng‐Li Lan. Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 2022; 26(7): 1955 doi: 10.1111/jcmm.17220
|
| 69 |
Prashant Kesharwani, Jyoti Chandra, Shahid Karim, Garima Gupta, Ritu Karwasra, Ajay Sharma. αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment. Journal of Drug Delivery Science and Technology 2024; 96: 105663 doi: 10.1016/j.jddst.2024.105663
|